These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6556710)

  • 1. Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies.
    Archer GL; Johnston JL; Vazquez GJ; Haywood HB
    Rev Infect Dis; 1983; 5 Suppl 3():S538-42. PubMed ID: 6556710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
    Lowy FD; Wexler MA; Steigbigel NH
    J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Archer GL; Vazquez GJ; Johnston JL
    J Infect Dis; 1980 Nov; 142(5):725-31. PubMed ID: 7462687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection.
    Lowy FD; Walsh JA; Mayers MM; Klein RS; Steigbigel NH
    Antimicrob Agents Chemother; 1979 Sep; 16(3):314-21. PubMed ID: 259421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Galetto DW; Boscia JA; Kobasa WD; Kaye D
    J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for experimental endocarditis due to Staphylococcus epidermidis.
    Kobasa WD; Kaye KL; Shapiro T; Kaye D
    Rev Infect Dis; 1983; 5 Suppl 3():S533-7. PubMed ID: 6635444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis.
    Karchmer AW; Archer GL; Dismukes WE
    Rev Infect Dis; 1983; 5 Suppl 3():S543-8. PubMed ID: 6556711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis.
    Ein ME; Smith NJ; Aruffo JF; Heerema MS; Bradshaw MW; Williams TW
    Antimicrob Agents Chemother; 1979 Nov; 16(5):655-9. PubMed ID: 260880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.
    Rouse MS; Wilcox RM; Henry NK; Steckelberg JM; Wilson WR
    Antimicrob Agents Chemother; 1990 Feb; 34(2):273-6. PubMed ID: 2327776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.
    Vazquez GJ; Archer GL
    Antimicrob Agents Chemother; 1980 Feb; 17(2):280-5. PubMed ID: 7387148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampin in the treatment of serious staphylococcal infections.
    Swanberg L; Tuazon CU
    Am J Med Sci; 1984; 287(3):49-54. PubMed ID: 6563847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis.
    Siebert WT; Moreland N; Williams TW
    J Infect Dis; 1979 Apr; 139(4):452-7. PubMed ID: 438546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis.
    Brandt CM; Rouse MS; Tallan BM; Laue NW; Wilson WR; Steckelberg JM
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1815-9. PubMed ID: 7486924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    Bayer AS; Lam K
    J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
    Yan Q; Karau MJ; Raval YS; Patel R
    Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms.
    Gagnon RF; Richards GK; Kostiner GB
    Adv Perit Dial; 1994; 10():189-92. PubMed ID: 7999824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis.
    Berry AJ; Johnston JL; Archer GL
    Antimicrob Agents Chemother; 1986 May; 29(5):748-52. PubMed ID: 3460523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis and Micrococcus species successfully treated with rifampicin combined with other antibiotics.
    Colebunders R; Ursi JP; Pattyn S; Snoeck J
    J Infect; 1985 Jul; 11(1):35-9. PubMed ID: 3875661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampin therapy of Staphylococcus epidermidis. Use in infections from indwelling artificial devices.
    Archer GL; Tenenbaum MJ; Haywood HB
    JAMA; 1978 Aug; 240(8):751-3. PubMed ID: 671704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.